Abstract
Background A hypothesized benefit of social participation is that it encourages people to be more physically active. However, limited evidence exists on the association between social participation over the life-course and physical activity in midlife. We sought to apply a life-course framework to examine the association of social participation and device measured physical activity in midlife in the UK.
Methods We used the 1970 British Birth Cohort Study (BCS70), which includes all people born in Britain during a single week in 1970. Social participation was assessed at ages 16, 30, 34 and 42. Physical activity was measured by accelerometery at age 46, as mean daily step count and time spent in Moderate to Vigorous Physical Activity (MVPA). The associations of social participation and physical activity were tested using two different life-course models: the sensitive period model and the accumulation model.
Results Individuals with medium and high participation compared to no social participation over their life-course had higher mean daily step count and MVPA in midlife, supporting the accumulation model. In the sensitive period model, only those that actively participated at age 42 had higher mean daily steps and MVPA compared to those who did not participate.
Conclusion Our study provides empirical evidence on the importance of sustaining social participation at all ages over the life-course rather than at a particular timepoint of someone’s life. Interventions to promote social participation throughout the life-course could be an avenue to promote physical activity in middle life.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Authors of this study received the following funding: Stergiani Tsoli received funding from the Economic and Social Research Council (ESRC) +3 for her doctoral studies. George Ploubidis received funding from ESRC [ES/W013142/1]. Daisy Fancourt received funding from the Wellcome Trust [205407/Z/16/Z] and the ESRC project WELLCOMM [ES/T006994/1]. Mark Hamer received funding from the British Heart Foundation [SP/15/6/31397] that supported the accelerometery data collection for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All source data were openly available through the UK's Data Service. Special licenced data for physical activity were also accessed through the same portal. https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=200001
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data used in this study are open access and can be accessed through the UKDS https://beta.ukdataservice.ac.uk/datacatalogue/series/series?id=200001
